Ignite Creation Date:
2025-12-25 @ 4:17 AM
Ignite Modification Date:
2025-12-26 @ 3:17 AM
Study NCT ID:
NCT06659120
Status:
RECRUITING
Last Update Posted:
2024-10-26
First Post:
2024-08-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Fremanezumab for the Prevention of Menstrually-related Migraine Attacks
Sponsor:
Insel Gruppe AG, University Hospital Bern
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-09
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-08-12
First Submit QC Date:
None
Study First Post Date:
2024-10-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-23
Last Update Post Date:
2024-10-26
Last Update Post Date Type:
ACTUAL